Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 2Behavior 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Transportation × Clear all
NCT06628167 2026-03-24

LCS II

Abramson Cancer Center at Penn Medicine

Phase NA Completed
252 enrolled 7 charts
Thoracic

Lung Neoplasms

NCT06207435 2025-09-02

LCS

Abramson Cancer Center at Penn Medicine

Phase NA Completed
242 enrolled 8 charts
Thoracic

Behavior, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡